Public Employees Retirement System of Ohio bought a new stake in BioAge Labs, Inc. (NASDAQ:BIOA – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 13,760 shares of the company’s stock, valued at approximately $57,000.
BioAge Labs Price Performance
Shares of BIOA stock opened at $5.60 on Wednesday. The company has a 50-day moving average price of $4.85. BioAge Labs, Inc. has a twelve month low of $2.88 and a twelve month high of $26.62.
BioAge Labs (NASDAQ:BIOA – Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.60) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($0.04).
Analyst Ratings Changes
Get Our Latest Stock Report on BioAge Labs
BioAge Labs Company Profile
We are a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Our technology platform and differentiated human datasets enable us to identify promising targets based on insights into molecular changes that drive aging.
Read More
- Five stocks we like better than BioAge Labs
- Investing In Preferred Stock vs. Common Stock
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- Why Invest in 5G? How to Invest in 5G Stocks
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- Health Care Stocks Explained: Why You Might Want to Invest
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for BioAge Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioAge Labs and related companies with MarketBeat.com's FREE daily email newsletter.